Communiqués BioGaia AB

Actions

BIOG B

SE0017769995

Produits pharmaceutiques

Marché Fermé - Nasdaq Stockholm 18:00:00 28/08/2026			Varia. 5j.	Varia. 1 janv.
115,30 ^SEK	-0,43%		-0,52%	+8,57%

28/08	Worldquant prend une position vendeuse publique dans Biogaia	FW
24/08	Citadel Advisors ne figure plus parmi les vendeurs à découvert déclarés de BioGaia	FW

Communiqués

17/07	BioGaia AB: Interim Report January – June 2026	PU
17/07	BioGaia AB: Interim Report January - June 2026	AQ
02/07	BioGaia : Invitation to media and analyst briefing for BioGaia Q2 2026 report	PU
02/07	BioGaia : Invitation to media and analyst briefing for BioGaia Q2 2026 report	PU
18/06	BioGaia : subsidiary introduces a complete skincare routine for babies and children	PU
18/06	BioGaia : subsidiary introduces a complete skincare routine for babies and children	PU
10/05	BioGaia : Bulletin from Annual General Meeting of BioGaia AB (Bulletin from Annual General Meeting of BioGaia AB publ)	PU
07/05	Bulletin from Annual General Meeting of BioGaia AB (publ)	AQ
07/05	BioGaia : launches BioGaia Protectis Plus – next‑generation patented probiotic drops	PU
07/05	BioGaia : Interim Management Statement Q1 2026	PU
07/05	BioGaia : launches BioGaia Protectis Plus - next‑generation patented probiotic drops	PU
07/05	BioGaia AB: Interim Management Statement January - March 2026	AQ
30/04	BioGaia : Invitation to media and analyst briefing for BioGaia Q1 2026 report	PU
28/04	BioGaia : research confirms effectiveness of patented LongevityGuard technology in extending probiotic shelf life	PU
30/03	BioGaia : The Nominating Committee´s motivated statement (The Nominating Committee´s motivated statement)	PU
30/03	BioGaia : Renumeration Report 2025 (Remuneration report v8 1)	PU
30/03	BioGaia : Notice to attend the Annual General Meeting of BioGaia AB (Notice to attend the Annual General Meeting of BioGaia AB publ)	PU
30/03	Notice to attend the Annual General Meeting of BioGaia AB (publ)	AQ
30/03	BioGaia : Corporate Governance Report 2025	PU
30/03	BioGaia : Annual and Sustainability Report 2025 (online version)	PU
30/03	BioGaia : Annual and Sustainability Report 2025 (print version)	PU
30/03	BioGaia Annual and Sustainability Report 2025 published	AQ
20/03	BioGaia : 10-year follow-up study shows infant probiotics are positively associated with a reduction of childhood functional abdominal pain	PU
17/03	BioGaia exercises option to acquire remaining shares in Nutraceutics	AQ
26/02	BioGaia : extends long-standing distribution partnership with Ewopharma	PU